BCR-ABL Tyrosine Kinase Inhibitors: Which Mechanism(s) May Explain the Risk of Thrombosis?

Hélène Haguet, Jonathan Douxfils, Christian Chatelain, Carlos Graux, François Mullier, Jean-Michel Dogne

Résultats de recherche: Contribution à un journal/une revue › Article de revue

langue originaleAnglais
Pages (de - à)e68-e88
journalTH Open
Volume02
Numéro de publication1
Les DOIs
étatPublié - 2018

Citer ceci

Haguet, Hélène ; Douxfils, Jonathan ; Chatelain, Christian ; Graux, Carlos ; Mullier, François ; Dogne, Jean-Michel. / BCR-ABL Tyrosine Kinase Inhibitors : Which Mechanism(s) May Explain the Risk of Thrombosis?. Dans: TH Open. 2018 ; Vol 02, Numéro 1. p. e68-e88.
@article{66a27f13c8b24ae3ad3cff556782919b,
title = "BCR-ABL Tyrosine Kinase Inhibitors: Which Mechanism(s) May Explain the Risk of Thrombosis?",
keywords = "BCR-ABL, arterial thrombotic events, tyrosine kinase inhibators, chronic myeloid leukemia",
author = "H{\'e}l{\`e}ne Haguet and Jonathan Douxfils and Christian Chatelain and Carlos Graux and Fran{\cc}ois Mullier and Jean-Michel Dogne",
year = "2018",
doi = "DOI: 10.1055/s-0038-1624566",
language = "English",
volume = "02",
pages = "e68--e88",
journal = "TH Open",
issn = "2512-9465",
publisher = "Thieme Medical Publishers",
number = "1",

}

Haguet, H, Douxfils, J, Chatelain, C, Graux, C, Mullier, F & Dogne, J-M 2018, 'BCR-ABL Tyrosine Kinase Inhibitors: Which Mechanism(s) May Explain the Risk of Thrombosis?', TH Open, VOL. 02, Numéro 1, p. e68-e88. https://doi.org/DOI: 10.1055/s-0038-1624566

BCR-ABL Tyrosine Kinase Inhibitors : Which Mechanism(s) May Explain the Risk of Thrombosis? / Haguet, Hélène; Douxfils, Jonathan; Chatelain, Christian; Graux, Carlos; Mullier, François; Dogne, Jean-Michel.

Dans: TH Open, Vol 02, Numéro 1, 2018, p. e68-e88.

Résultats de recherche: Contribution à un journal/une revue › Article de revue

TY - JOUR

T1 - BCR-ABL Tyrosine Kinase Inhibitors

T2 - Which Mechanism(s) May Explain the Risk of Thrombosis?

AU - Haguet, Hélène

AU - Douxfils, Jonathan

AU - Chatelain, Christian

AU - Graux, Carlos

AU - Mullier, François

AU - Dogne, Jean-Michel

PY - 2018

Y1 - 2018

KW - BCR-ABL

KW - arterial thrombotic events

KW - tyrosine kinase inhibators

KW - chronic myeloid leukemia

U2 - DOI: 10.1055/s-0038-1624566

DO - DOI: 10.1055/s-0038-1624566

M3 - Review article

VL - 02

SP - e68-e88

JO - TH Open

JF - TH Open

SN - 2512-9465

IS - 1

ER -

Haguet H, Douxfils J, Chatelain C, Graux C, Mullier F, Dogne J-M. BCR-ABL Tyrosine Kinase Inhibitors: Which Mechanism(s) May Explain the Risk of Thrombosis? TH Open. 2018;02(1):e68-e88. https://doi.org/DOI: 10.1055/s-0038-1624566

Accès au document

    Contenu associé

    Projets

    The TiTKI Project - evaluation of the risk of thrombosis associated with the use of tyrosine kinase inhibitors

    Projet: Recherche